Means Investment CO. Inc. increased its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 29.9% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 6,316 shares of the healthcare conglomerate's stock after purchasing an additional 1,454 shares during the quarter. Means Investment CO. Inc.'s holdings in UnitedHealth Group were worth $3,308,000 at the end of the most recent reporting period.
A number of other institutional investors have also added to or reduced their stakes in the stock. Walter & Keenan Wealth Management LLC IN ADV increased its position in UnitedHealth Group by 4.3% during the 1st quarter. Walter & Keenan Wealth Management LLC IN ADV now owns 3,731 shares of the healthcare conglomerate's stock worth $1,954,000 after purchasing an additional 155 shares in the last quarter. Blue Trust Inc. increased its position in UnitedHealth Group by 9.8% during the 1st quarter. Blue Trust Inc. now owns 9,213 shares of the healthcare conglomerate's stock worth $4,825,000 after purchasing an additional 823 shares in the last quarter. Curran Financial Partners LLC increased its position in UnitedHealth Group by 4.0% during the 1st quarter. Curran Financial Partners LLC now owns 756 shares of the healthcare conglomerate's stock worth $396,000 after purchasing an additional 29 shares in the last quarter. CLG LLC increased its position in UnitedHealth Group by 1.9% during the 1st quarter. CLG LLC now owns 1,513 shares of the healthcare conglomerate's stock worth $793,000 after purchasing an additional 28 shares in the last quarter. Finally, Advisory Resource Group grew its holdings in UnitedHealth Group by 2,136.4% during the 1st quarter. Advisory Resource Group now owns 9,840 shares of the healthcare conglomerate's stock worth $5,154,000 after acquiring an additional 9,400 shares during the last quarter. 87.86% of the stock is currently owned by institutional investors and hedge funds.
Insider Activity at UnitedHealth Group
In related news, CEO Patrick Hugh Conway sold 589 shares of the business's stock in a transaction that occurred on Tuesday, June 10th. The shares were sold at an average price of $305.00, for a total transaction of $179,645.00. Following the completion of the transaction, the chief executive officer now owns 10,398 shares of the company's stock, valued at approximately $3,171,390. The trade was a 5.36% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Stephen J. Hemsley bought 86,700 shares of the company's stock in a transaction on Friday, May 16th. The shares were bought at an average price of $288.57 per share, with a total value of $25,019,019.00. Following the completion of the transaction, the chief executive officer now owns 679,493 shares of the company's stock, valued at $196,081,295.01. The trade was a 14.63% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders have bought 109,408 shares of company stock valued at $31,607,768 over the last ninety days. Corporate insiders own 0.28% of the company's stock.
Analysts Set New Price Targets
A number of equities research analysts have weighed in on UNH shares. Truist Financial reissued a "buy" rating and set a $360.00 target price (down from $580.00) on shares of UnitedHealth Group in a report on Monday, May 19th. Wall Street Zen lowered shares of UnitedHealth Group from a "buy" rating to a "hold" rating in a report on Saturday, May 24th. HSBC reissued a "reduce" rating and set a $270.00 target price (down from $490.00) on shares of UnitedHealth Group in a report on Wednesday, May 21st. TD Securities reaffirmed a "hold" rating and issued a $308.00 price objective (down from $520.00) on shares of UnitedHealth Group in a research note on Monday, May 19th. Finally, Erste Group Bank lowered shares of UnitedHealth Group from a "strong-buy" rating to a "hold" rating in a research note on Wednesday, April 30th. One equities research analyst has rated the stock with a sell rating, nine have given a hold rating and sixteen have issued a buy rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $426.52.
Get Our Latest Stock Report on UnitedHealth Group
UnitedHealth Group Stock Performance
UNH opened at $306.90 on Friday. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.71. The company's fifty day moving average price is $365.09 and its two-hundred day moving average price is $465.88. UnitedHealth Group Incorporated has a 1-year low of $248.88 and a 1-year high of $630.73. The company has a market cap of $278.40 billion, a price-to-earnings ratio of 12.85, a PEG ratio of 1.44 and a beta of 0.44.
UnitedHealth Group (NYSE:UNH - Get Free Report) last released its quarterly earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing analysts' consensus estimates of $7.29 by ($0.09). UnitedHealth Group had a net margin of 5.39% and a return on equity of 26.29%. The firm had revenue of $109.58 billion for the quarter, compared to the consensus estimate of $111.56 billion. During the same period in the previous year, the business earned $6.91 earnings per share. On average, analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.
UnitedHealth Group Increases Dividend
The company also recently declared a quarterly dividend, which will be paid on Tuesday, June 24th. Investors of record on Monday, June 16th will be given a dividend of $2.21 per share. This is a positive change from UnitedHealth Group's previous quarterly dividend of $2.10. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.88%. The ex-dividend date of this dividend is Monday, June 16th. UnitedHealth Group's dividend payout ratio (DPR) is presently 37.02%.
UnitedHealth Group Company Profile
(
Free Report)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Read More
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report